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Highlights 
 Cell spheroids are spherical aggregates best mimicking the tissue 
microenvironment. 
 Spheroid culture better recapitulates the in-vivo condition in microfluidic chips. 
 Microfluidics provides rapid spheroid formation with size uniformity and control. 
 These chips contain microwells, microstructures, droplet generators, etc. 




A cell spheroid is a three-dimensional (3D) aggregation of cells. Synthetic, in-vitro 
spheroids provide similar metabolism, proliferation, and species concentration gradients to 
those found in-vivo. For instance, cancer cell spheroids have been demonstrated to mimic in-
vivo tumor microenvironments, and are thus suitable for in-vitro drug screening. The first part 
of this paper discusses the latest microfluidic designs for spheroid formation and culture, 
comparing their strategies and efficacy. The most recent microfluidic techniques for spheroid 
formation utilize emulsion, microwells, U-shaped microstructures, or digital microfluidics. 
The engineering aspects underpinning spheroid formation in these microfluidic devices are 
therefore considered. In the second part of this paper, design considerations for microfluidic 
spheroid formation chips and microfluidic spheroid culture chips (µSFCs and µSCCs) are 
evaluated with regard to key parameters affecting spheroid formation, including shear stress, 
spheroid diameter, culture medium delivery and flow rate. This review is intended to benefit 
the microfluidics community by contributing to improved design and engineering of 
microfluidic chips capable of forming and/or culturing three-dimensional cell spheroids. 
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1. Introduction 
The term ‘multicellular spheroid’, hereafter abbreviated to ‘spheroid’, refers to three-
dimensional (3D), well-rounded cell aggregations that consist of multiple single cells 
(epithelial, mesenchymal, endothelial, etc.). To form spheroids, cells suspended in culture 
medium are injected into specialized microenvironments in cell culture dishes or microfluidic 
chips, wherein they establish cell-cell interactions and form compacted, multicellular spheroid 
structures. A common misconception exists in the literature in relation to the term spheroid. 
Some loose aggregates or spatial distributions of cells in hydrogel droplets have been termed 
spheroid cultures, despite lacking cell-cell interactions. Hirschhaeuser et al. and Weiswald et 
al. emphasized that spheroids are compact and spherical in shape, not loose, easily 
fragmented cell aggregates [1, 2]. The compactness of spheroids endows them with several 
features analogous to those of in-vivo tumor tissues [3]. These features make spheroids a more 
suitable tool for in-vitro drug screening assays than two-dimensional (2D)-monolayer cell 
cultures [4].  
In fact, several previous works have suggested that 2D-monolayer cell cultures should be 
replaced with multicellular tumor spheroids that better recapitulate the in-vivo environment 
[5-9]. Compared to 2D-monolayers, cancer cells cultured in 3D spheroids are more resistant 
to anticancer drugs [10-18] and photodynamic therapy [13], reflecting differences in cell 
secretions, hypoxia, species concentration, and proliferative gradients [8, 14, 19]. Furthermore, 
in 2D culture, cell-cell interactions are confined to the narrow common area between cells, 
while direct contact exists between each cell and both culture medium and the underlying 
culture substrate [15]. The substrate is usually made of polystyrene or other plastics which are 
impermeable and extremely rigid, unlike the natural tissue. At the same time, direct cell-
culture medium contact in monolayer cultures leads to more significant exposure of cells to 
nutrients, oxygen, and drugs [20]. This often causes errors in estimating drug dosages 
required to kill cancer cells in actual patients. More broadly, several studies have illustrated 
that gene expression patterns are altered in 2D-monolayer cancer cell cultures, whereas results 
obtained from spheroids better recapitulate the molecular profiles of tumors in-vivo [21, 22]. 
An alternative approach for 3D pharmacological screening is the use of biopsied tumor 
tissues [19]. Although biopsied samples have historically been used for diagnostic purposes, 
they can also be employed as informative substrates for ex-vivo drug testing. However, it is 
challenging to access sufficient cellular material for such testing, mainly from metastatic sites. 
Furthermore, biopsied tissues experience both oxygen and nutrient depletion following 
surgical removal, as well as temperature variations and mechanical stresses that may 
adversely affect the tumor’s microenvironment [23]. As such, 3D biopsied tumor samples 
lack necessary reproducibility [24] and compatibility with high-throughput drug screening 
approaches.  
Compared to 2D cultures and biopsy samples, multicellular spheroids have several 
unique features that make them highly relevant models for in-vitro drug screening. First, 3D 
spheroids establish gradients in proliferation rate that result in creation of a cell layout 
consisting of three layers (Figure 1A): i) the proliferating layer - a rapidly proliferating layer 
comprising the outer 4-5 cell strata (60±10 µm thickness) [17] - which mimics sites adjacent 
to angiogenesis-induced capillaries; ii) the inactive layer - an inactive and inert intermediate 
layer, and; iii) the necrotic core: a hypoxic, necrotic core recapitulating tumor sites far from 
blood (which normally appear in large spheroids with diameters more than 500 µm [3, 17, 25, 
26]. Second, 3D spheroids experience reduced drug, nutrient and gas exchange due to limited 
permeability. This generates steep, physiologically relevant gradients, particularly in large 
spheroids [1, 8, 27, 28] (Figure 1B). Third, cell-cell and cell-ECM attachments differ from 2D 














strongly affect cytotoxicity assays. Fourth, spheroids have exponential growth rates [28, 29] 
that correspond to in-vivo data [30, 31].  
 
 
Fifth, chemotaxis-driven cell movements – which exist in tumor tissue in-vivo [32, 33] – 
are also observed in spheroid cultures. Sixth, an acidic environment exists in the core of large 
spheroids (low pH) due to anaerobic activities and production of lactic acid [34] (Figure 1C). 
Cell spheroids can also be formed from co-cultures (Figure 1D). These are advantageous 
for cancer research and regenerative medicine, as they better recapitulate the complexity of 
the natural tissue [35]. Such co-culture spheroids may be formed by cancer cells with 
fibroblasts [36], human umbilical vein endothelial cells [37], MC3T3-E1 cell [38] and 
pericytes [39]. Co-culture of hepatocytes and hepatic stellate cells (non-cancerous cells) was 
also performed in 3D spheroids by Lee et al. [40]. 
Although non-microfluidic methods [25, 28, 38, 41-55] for spheroid formation and 
culture have played essential roles in the development of this field, they are less efficient than 
microfluidic chips at mimicking in-vivo environments. Such non-microfluidic methods have 
deficiencies such as variable spheroid diameters, laborious handling, and low-throughput, 
which limit their efficacy in biological research. Moreover, the static microenvironment of a 
conventional microwell or hanging droplet (HD) culture plate causes the fast depletion of 
oxygen and nutrients while increasing waste concentrations and osmolality [56]. This directly 
influences spheroids and subsequent results from drug testing [57]. Other conventional 
methods such as spinner flasks and stirred-tanks [25, 53] are slow approaches that require 
large amounts of culture medium and space. These methods also result in significant 
variations in spheroid sizes, as well as harmful effects on cells, mainly due to shear stress [58].   
Recent advances in microfluidics have contributed significantly to 3D spheroid research 
by addressing the aforementioned limitations [59, 60]. The significant advantages of 
microfluidic systems include providing controlled mixing [61], chemical concentration 
gradients, lower reagent consumption, continuous perfusion and precise control of pressure 
and shear stress on cells [62]. A remarkable feature of microfluidic chips is that cells can be 
cultured in a dynamic microenvironment to better recapitulate the tissue environment. Lee et 
al. reported that hepatocyte cell viability was lower in static cell cultures when compared with 
dynamic conditions in microfluidic devices after several days of culture [40]. Furthermore, 
Ruppen and co-workers experimentally demonstrated that cancer spheroids exposed to 
continuous perfusion of drugs showed higher resistivity than spheroids under static conditions 
(in a microwell plate) [8]. Indeed, continuous perfusion culture improves oxygen and nutrition 
supply for cells, as previously predicted computationally [63-67]. It has also been reported 
that gene expression profiles collected from hepatocyte cells cultured on a microfluidic chip 
with dynamic flow conditions showed more hepatocyte-specific characteristics than cells in 
static conditions [68].  
There are several review articles in the literature about cancerous and non-cancerous 
spheroids, analyzing the conventional methods for spheroid formation [69-71], as well as the 
spheroid potential for high-throughput screening (HTS) [56, 72] and regenerative medicine 
[35]. Among the most recent of these, Hirschhaeuser and colleagues elaborated on the 
potential use of spheroids in cancer research as well as the importance of co-cultures and 
cancer stem cell spheroids [1]. In a comprehensive work, Nath et al. investigated conventional 
methods, novel non-microfluidic methods and on-chip microfluidic methods for spheroid 
formation, while also highlighting applications of tumor spheroids in cancer research [24]. 
Weiswald and co-workers discussed four spheroid models currently being used in cancer 
research, emphasizing their spherical shape and compact configuration [2]. Our group 
recently published a review on microfluidic methods for spheroid formation in which the 














were discussed [73]. However, we did not address the design considerations or cell trapping 
strategies for microfluidic systems from an engineering point of view. Other works have 
reviewed the importance of microfluidics in cancer cell culture and drug discovery [74-80], as 
well as considering various microfluidic chips enabling 3D cell culture with cancerous or non-
cancerous cells [9, 81-86]. To the best of our knowledge, there is currently no review article 
available in the literature discussing detailed engineering features and design considerations 
for such microfluidic systems.  
Herein, we refer to continuous-flow microfluidic chips that both form and culture 
spheroids in the same device as microfluidic spheroid formation chips (µSFCs). Although 
there are numerous µSFCs, they can be divided into two principal categories: 1) those using 
emulsion-based techniques, or; 2) those utilizing microwells or U-shaped microstructures. 
Some other devices under investigation are culture-only chips, meaning that spheroid 
formation must first proceed using different methods outside the chip, before introduction to 
the chip for culture and drug efficacy testing [6, 8, 87]. We refer to these latter devices as 
microfluidic spheroid culture chips (µSCCs).   
This review discusses and categorizes various µSFCs and µSCCs based on their 
underlying spheroid formation mechanism and culture strategy, with a particular emphasis on 
engineering aspects. In the following sections, different continuous-flow µSFCs and µSCCs 
are first reviewed. Then, an introduction to various digital microfluidic methods for spheroid 
formation is presented. In the second part of this review, design parameters that enhance 
engineering of such systems are considered. Overall, this review collates design 
considerations and ideas from an immense body of published literature to support researchers 
in optimizing design and use of µSFCs and µSCCs.  
2. Continuous-flow microfluidic spheroid formation and culture  
Microfluidic platforms can be utilized for long-term perfusion cell culture while 
maintaining high cell viability, as shown in previous studies [6, 18, 39, 40, 88, 89]. Cell 
viability depends on the continuous supply of nutrients and oxygen, removal of waste 
products, low shear stress and the biocompatibility of materials. A number of characterization 
assays such as live/dead cell staining, drug testing, molecular profiling (e.g., FISH), as well as 
chemical, mechanical [90] and electrical stimulations are possible within microfluidic chips. 
These devices can also be coupled with on-chip tools for precise monitoring [91] and 
measurement of pH, oxygen level [92] and cell-secreted biomarkers [93], enabling a myriad 
of applications.  
The µSFCs are designed to enhance the spheroid formation process by: providing size 
control; allowing rapid aggregation; requiring minimal interaction between the user and the 
device, and; replacing manual handling with engineered and automated procedures. These 
important capabilities have been achieved with the aid of transparent and biocompatible 
materials, in particular, poly (dimethylsiloxane) (PDMS) [94]. Given its hydrophobic nature 
and gas permeability, PDMS has been shown to be an ideal material for both spheroid 
formation and long-term perfusion culture with minimum cellular attachment [17, 94, 95]. 
Nonetheless, treatments with various chemical materials are frequently used to further 
enhance PDMS hydrophobicity. These materials include polyvinyl alcohol (PVA) [17], 
bovine serum albumin (BSA) [40, 88] and Synperonic F-108 [96]. Coating microchannel 
walls with a layer of poly (hydroxyethyl methacrylate) hydrogel has also been shown to 
optimize spheroid formation [13]. Contrastingly, as required for specific applications [94, 97], 
PDMS also can become hydrophilic by using plasma treatment. 
2.1. Microfluidic spheroid formation chips (µSFCs) 
The µSFCs can be categorized into two main groups that differ in spheroid formation 
procedure: emulsion-based spheroid formation and; microwell or U-shaped microstructure-
based spheroid formation. Both have specific advantages and limitations that are briefly 














evaluate the most critical parameters involved. Second, microwell and U-shaped 
microstructures are discussed along with their working principles and challenges. Moreover, 
the hydraulic-electric analogy for proper design of µSFCs is introduced. 
2.1.1. Emulsion-based techniques 
Flow-focusing droplet generators have been the subjects of many studies due to the 
uniformity in droplet and spheroid sizes produced by them, as well as their high-throughput 
continuous operation [98]. Single- (Figure 2A) [36, 99, 100], double- (Figure 2B) [101, 102] 
and triple- (Figure 2C) [98] emulsion droplet generation techniques have been utilized in 
µSFCs. Flow focusing devices for this application exist in either axisymmetric [101] or non-
axisymmetric [36, 98, 103] configurations. The nature of this method facilitates the fast 
production of microdroplets and thus high-throughput spheroid formation (HTSF). Droplet 
generation frequencies up to 50 droplets per second [104] and 200 droplets per minute have 
been achieved using collagen [99] and alginate [105] hydrogels.   
 
 
Several liquids are used for cell encapsulation and spheroid formation in µSFCs with 
different configurations around the core flow. Cell suspension (CS) in oil (O) emulsion (i.e., 
CS/O) [106] and cell-dispensed hydrogel (Gel) in oil (i.e., Gel/O) droplet generation [36, 107] 
are among the single-emulsion methods which are widely used. Cell suspension in oil in 
culture medium (CM) (i.e. CS/O/CM) [102] and CS/Gel/CM [101] are double-emulsion 
techniques. The CS/Gel/CM double-emulsion technique can enhance droplet uniformity and 
entrap cells firmly within the droplet. It is facilitated by encapsulating the cell-containing core 
droplet within an alginate hydrogel shell [101, 108] that acts as an impermeable barrier with 
respect to the cells. However, in contrast to the CS/O/CM method, gelation is required in the 
CS/Gel/CM method. Using mineral oil as a barrier instead of hydrogel enhances oxygen 
transport to the droplets, reflecting the higher permeability of mineral oil to small molecules 
[109]. Although these barriers produce nutrient concentration gradients within the droplets, 
they act as an interface between the culture medium and the encapsulated cells which protects 
cells from high shear stress.  
Hydrogels in emulsion spheroid formation 
High proliferative cancer cells quickly aggregate with a spheroid shape after being 
encapsulated in a hydrogel droplet [98]. However, other cell types such as mesenchymal stem 
cells are not able to form spheroid aggregates in a solid-like hydrogel [58]. The high 
concentration of alginate and agarose [110] causes higher stiffness and disturbs cell 
proliferation [108]. Yu et al. reported that alginate concentrations around 3% (v/v) and higher 
reduce the proliferation of encapsulated tumor cells within droplets due to high rigidity [108]. 
They found that alginate concentrations of 1.5% (v/v) to 2% (v/v) are suitable for spheroid 
generation, permitting cell proliferation while still entrapping cells firmly within droplets - 
despite low alginate concentrations.  
The solid core formed after droplet gelation not only hinders cell proliferation but also 
prevents cells from establishing the cell-cell interactions necessary for compact spheroid 
formation. However, this problem is resolved by the aid of matrigel. As matrigel is digestible 
by cells, the solid core is degraded after a short time and the adverse effects disappear [107, 
111]. As a result, mixtures of alginate and Matrigel (1:1 v/v) for cell-dispensed core flow 
generate droplets with enhanced droplet uniformity as well as yielding spheroid formation in a 
shorter time [107, 112]. 
Collagen, a typical hydrogel existing in our body, has priority over other hydrogels for 
cell culture as it can properly mimic the in-vivo microenvironment. In conventional methods, 
collagen droplets are made via emulsification [113] or simple droplet dispensing [114-116]. 
As a consequence, the resulting droplets have non-uniform diameters due to the coalescence 














collagen droplet formation causes cell death in droplets as a consequence of centrifugal and 
compressive forces exerted during the microsphere extraction process [99].  
Microcapsules having liquefied alginate in the core, in addition to poly (L-lysine) and 
alginate as barriers, are also utilized for spheroid formation. In these methods, the alginate 
bead that fills the core is liquefied with tri-sodium citrate treatment [117], despite such 
treatment being reported to perturb live encapsulated cells [98]. Another drawback is the 
excess pressure and mechanical stress imposed on spheroid cells by the alginate-poly (L-
lysine) barrier, which adversely affects cell proliferation and final spheroid size [98, 101]. 
Sodium citrate is also used for liquefying alginate microdroplets after gelation to facilitate the 
retrieval of spheroids formed within the droplets [100].  
Droplet stabilization 
Chan et al. reported that the use of amphiphilic surfactants (i.e., showing both 
hydrophobic and hydrophilic behaviors) helps to maintain droplet stability [102]. They also 
reported an acceleration in spheroid formation by decreasing the duration time from one day 
to 150 minutes. Moreover, they monitored spheroid formation using labels for collagen type I 
and laminin, as well as immunostaining for E-cadherin and integrin-α5β1 to assess cell-cell 
and cell-matrix interactions and adhesions. Kim et al. used glycerol to adjust viscosity in the 
cell suspension constituting the core flow in an on-chip CS/Gel/CM spheroid generation 
method [98]. Given that viscosity was increased, the cross-sectional geometry of the droplet 
took a more circular form. However, glycerol had devastating effects on cell viability, 
reducing it to just 13% in a glycerol concentration of 20% [98]. Using viscous oil as the 
droplet shell instead of a hydrogel obviates the need for viscosity adjustments in CS/O/CM 
method [102]. Adding Span 80 surfactant to the mineral oil further stabilizes the droplets 
formed in the CS/O single-emulsion technique [99, 105, 107]. 
Flow rate 
In emulsion-based techniques, droplet generation frequency and droplet diameter are 
adjustable by varying the flow rates. Smaller droplets are normally obtained by increasing the 
rate of sheath flow [102]. In addition, the thickness of the capsule shell can be adjusted by 
changing the flow rates of different phases [101] or varying the channel dimensions of the 
microfluidic device [102]. In fact, the shell thickness is related to the ratio between the 
volume flow rates of the sheath and core flows [98]. Flow rate is also crucial for droplet 
anchorage after droplet generation [36, 103]. The flow should be adjusted to allow the 
droplets to settle in traps designed for spheroid formation and culture. High flow rates push 
the droplets towards the outlet; whereas, low flow rates cause channel clogging in some 
µSFCs [36, 104].  
Droplet anchorage and retrieval  
Proper droplet anchorage is crucial for on-chip gelation, culture perfusion, spheroid 
formation and drug screening. Multiwell plates [100, 105], Petri dishes [107] and cell culture 
flasks [108] have frequently been used for droplet storage. However, these platforms do not 
inhibit droplet coalescence. Several microfluidic chips have been designed which can 
facilitate high-throughput droplet anchorage with hundreds of anchoring sites, solving this 
problem. One configuration contains a vast number of droplet arrays. Each array has tens of 
anchor sites which resemble two out-of-phase sinusoid functions placed in parallel (Figure 
3A) [36, 103].  
Droplets squeeze through the narrow passing throats one by one to reach the downstream 
trap, driven by pressure exerted on them via pumping. The design principles in this 
configuration are based on droplet size, viscosity and surface tension, which together shape 
device performance. The flow rate and the resulting pressure gradient along the channel also 
play essential roles in avoiding droplet coalescence. Although droplet coalescence has been 
prevented by this method, both throat and trap sizes must be designed to properly facilitate 
















McMillan et al. fabricated a µSFC having a high-throughput droplet storage array 
consisting of 2000 droplet sites that suited radiation assays performed on tumor spheroids 
(Figure 3B) [103]. However, it was not possible to have a culture medium or drug solution 
flow through the microchip since the design had been set for radiation assays. Sabhachandani 
et al. generated a similar design that was able to facilitate a continuous flow of medium and 
drug [36]. The only possible problem remaining with this anchorage design is flow blockage. 
As the medium flows continuously, the induced pressure gradient pushes droplets 
downstream, such that a gelled droplet may be pushed to the outlet of its trap, thereby 
blocking the flow. The presence of a gap between traps and the bottom surface of the top 
PDMS layer can eliminate this problem by permitting continued medium flow. In another 
design by Tomasi et al., the chip contained over 5000 microwells for droplet storage [104]. 
They used V-shaped trails to distribute generated droplets homogeneously over the anchoring 
microwells (Figure 3C). The strengths of this device include rapid droplet generation, with 
10-50 droplets formed per second - filling all 5000 available anchors in less than 10 minutes.   
Immediately after droplet formation, the surrounding sheath fluid usually has to be 
removed and replaced with culture medium or drug solution. In one design this was achieved 
through the application of magnetic forces using magnetic nanoparticles [105] immediately 
after on-chip droplet formation. Nanoparticles were dispensed into the cell suspension to 
cause a deviation in the droplets’ path within the magnetic field. Consequently, droplets leave 
the oil stream and enter the culture medium, enabling their retrieval (Figure 3D). Wang et al. 
guided microdroplets in oil to a microwell on the chip which contained culture medium in its 
lower half (Figure 2A) [100]. Thus, after sedimentation, droplets were easily extracted from 
the culture medium for further use.  
2.1.2. Microwells and U-shaped microstructures 
In the last decade, a large number of microfluidic platforms have been designed for 
spheroid formation and culture using microwells [6, 7, 39, 96] or U-shaped microstructures 
[16, 18, 118-121] embedded in the device. These structures are designed to help spheroid 
generation within a shorter period [122, 123], with controllable and uniform diameters [124, 
125] and a compact spheroid shape [17, 120]. Recently, we employed numerical simulations 
to find the necrotic core and hypoxic zone in a U-shape system containing spheroid [126] and 
compare the performance of such system in microfluidic platforms with either U-shaped 
barrier or microwell structure containing cell aggregates in toroidal shape [127]. 
U-shaped microstructures function either temporarily, using pneumatic actuation 
(Figure 4A) [119-121, 128], or permanently within the device (Figure 4B-C) [118, 121]. Liu 
et al. fabricated µSFCs which had temporary U-shaped pneumatic microstructures for high-
throughput spheroid formation, culture assessments and drug efficacy tests (Figure 4A) [120, 
128]. A large number of these U-shaped microstructures are usually embedded (e.g. 360 [120], 
28 [18], 512 [129]) in each chamber of µSFCs to trap most of the cells introduced into the 
chip [18, 118, 120, 121, 128]. Spheroid diameters depend on microstructure size, while the 
relative position of microstructures is essential for efficient cell trapping. Kim et al. 
investigated cell trapping efficiency and related design optimization using computational fluid 
dynamics (CFD) simulation first, followed by experimental validation [130]. The detailed 
information regarding CFD simulations of U-shaped microstructures can be found in the 


















Hydrogel droplets can also be trapped within these microstructures [18]. Yu et al. 
designed a µSFC, named microsieve, containing triple-portion U-shaped microstructures to 
trap cell-containing alginate droplets (Figure 4B) [18]. Since cells were trapped within a 
hydrogel droplet, diffusion of oxygen and other species to the cells from culture medium was 
limited. Therefore, the design was enhanced by introducing junctions between three 
microstructure portions, thus facilitating better oxygen and nutrient transport.  
The fluid flowing towards a microstructure creates a stagnation region in its front. 
Consequently, species transport is facilitated via diffusion rather than a convective 
mechanism [121]. This stagnation region exerts forces on cells residing in the microstructure, 
thereby inducing more cell-cell interactions and faster spheroid formation [121]. Hence, 
spheroid formation time can be adjusted by flow rate, since the formation is affected by the 
stagnation pressure existing in front of the microstructure. However, high flow rates cause 
cells to escape from the narrow space between the microstructure edge and the PDMS slab 
[120, 121]. On the other hand, to hold spheroids within microstructures the flow should be 
sustained, thereby maintaining the necessary stagnation pressure [121]. Otherwise, the 
spheroids exit U-shaped microstructures and flow towards the outlet (Figure 4C).  
 
Microwell-based µSFCs have been utilized more than other techniques due to their 
simplicity and ease of operation [131-133]. In general, a microwell-based µSFC needs a 
specified number of microwells and a microchannel network to deliver the culture medium 
(Figure 5A-E). For spheroid generation, the cell suspension is introduced at the inlet, usually 
with a cell density of 105 to 107 cells/ml [6, 68, 96], depending on the cell type (Figure 5A). 
To achieve uniform cell seeding in microwells and uniformly sized spheroids, the cell 
suspension should fill the device entirely before cells begin to deposit in the microwells. The 
cells take several minutes to deposit on microwell bottoms and channel floors (Figure 5B). 
Excess cells that did not enter microwells should be rinsed out of the chip to avoid subsequent 
channel clogging [7, 68, 134] (Figure 5C). After that, cells begin to adhere to each other, form 
a spheroid (Figure 5D), and continue their growth with a continuous or intermittent supply of 
fresh culture medium (Figure 5E). Using more than one inlet and microwell-contained 
channel allows testing drugs with various concentrations, cell types and different spheroid 
sizes on a single microfluidic chip [134].  
 
 
Microchannels should be designed in a way that can prevent undesirable spheroid escape 
from the microwells (Figure 6A-F). Choi et al. [68] reported cells and spheroids escaping 
from the microwells when high flow rates were utilized in the main channel. Experimentally, 
it has been indicated that increasing the channel width [134] or decreasing its height [17] can 
limit spheroid escape. However, sometimes it is required to retrieve spheroids for flow 
cytometry analysis, stem cell differentiation-assays, etc., which necessitates spheroid ejection 
from the microwells. Rousset and colleagues performed a CFD study to obtain the flow rates 
necessary to deliver a sufficient lift force on spheroids to drive their exit from microwells [65]. 
However, these flow rates might create high shear stress on cells while pushing them upward. 
Therefore, an acceptable shear stress threshold (1 Pa) was applied as a constraint when 
calculating optimum geometrical parameters based on numerous simulations [65]. 
 
 
In order to equalize flow rates across several microchannels, flow resistance must be the 
same through all of them. Therefore, if channels have the same width and height, their lengths 
must also be equal to satisfy this requirement. Sinuous channels, often used in concentration 














precisely within a small area of the chip. Such channels can thus be applied for flow control 
purposes rather than including valves within microfluidic chips [88, 135]. 
Desired flow rates must also take into account the number of cells existing in the culture 
environment and their corresponding requirements for oxygen, nutrients and other factors. 
This is complicated by the fact that various species have limited solubility in water at any 
given temperature. For instance, this value is 1 gr/cm3 [136] for glucose and 0.007 gr/cm3 for 
oxygen in water at 37 C˚ [137]. Hence, one should consider both the amounts of these species 
present in culture medium and the corresponding uptake rates achieved by cells. However, 
these calculations are not sufficient to ensure that hypoxia or anoxia are avoided in the center 
of a spheroid cultured on a chip. The limited diffusion of glucose and oxygen to spheroids, 
combined with the specified geometry in which the spheroid is cultured, make the problem 
unpredictable. Thus, mathematical and numerical analyses combined with experimental 
investigations are needed [64-66, 138-140]. 
A major drawback of microstructure- or microwell-based µSFCs is their limited 
application for HTS. In other words, simultaneous drug tests with various combinations and 
concentrations have rarely been carried out on a single µSFC due to the lack of a suitable 
microchannel network. Most µSFCs, while achieving HTSF capacity, permit only one 
concentration of a drug, or one combination of drugs, to be applied to spheroids at any given 
time. Therefore, one has to employ several chips for each single drug concentration. Recently, 
Kwapiszewska et al. [6] and Zuchowska et al. [141] designed microwell-based µSFCs that 
facilitate simultaneous exposure of spheroids to different concentrations of the 5-fluorouracil 
anticancer drug. This advancement was achieved by coupling the µSFC with a CGG. In this 
design, microwells were arranged in a configuration compatible with commercial microplate 
readers for automated monitoring (Figure 6D).  
Hydraulic-electric analogy 
The hydraulic-electric analogy has helped microfluidic engineering integrate microfluidic 
chips with pressure drop adjustments and precise flow rates [142]. In designing µSFCs [16, 39, 
88] and µSCCs [8], the hydraulic-electric analogy has been used to direct the path of 
suspended cells or spheroids to desired on-chip locations (i.e., microwells, cell traps, etc.). By 
using this method, channel width, height, and length are computed to achieve desired flow 
rates and pressure drops. As the flow velocity and length scales are very small in microfluidic 
chips, the Reynolds number is usually below unity [143], thus ensuring a laminar flow regime 
[144, 145]. This fact helps designers efficiently compute flow rates, resistances and pressure 
drops by using the Poiseuille pressure drop equation in microchannel networks [146, 147]. In 
the hydraulic-electric analogy, the electric potential difference is analogous to the pressure 
drop, electric current corresponds to flow rate, and electrical resistance plays the role of the 
flow resistance [142]. This analogy introduces an acceptable method for flow calculations in 
biological microfluidics [8, 11, 16, 88, 135, 148].  
One design used two sets of channels named trapping and bypass. The channels had 
different resistances in order to divide flow rates such that the larger part of the fluid passed 
through the trapping channel while a small amount of fluid entered the bypass channel. 
Spheroids reaching the split in the channel are forced by the upstream flow to enter the 
trapping channel, thereafter stopping in the trap neck and blocking the flow inside that 
channel. This prevents further spheroids from entering, such that these move into the bypass 
channel and get trapped in the next empty trapping channel [8, 11]. McMillan et al. [149] 
designed a nearly identical device to trap cell-containing alginate droplets instead of spheroids. 
This mechanism has recently been adapted for single cell trapping by modifying the geometry 
and fluidic parameters [150]. 
In other works by Kim et al. [88, 135] and Ruppen et al. [39], the spheroid formation was 
achieved by driving a cell suspension towards individual microwells for sedimentation 














microchannel. This contrasts with typical microwell-based µSFCs, wherein one microchannel 
usually feeds tens of microwells [68, 134]. Nonetheless, flow rates and geometries must still 
be optimized such that cells can sediment without easily escaping through the exiting channel. 
For instance, if the channel height equals the entering one, most cells pass through the 
microwell and are lost. Therefore, the exiting channel has a reduced height relative to the 
entering one, enhancing trapping. Kim et al. [88, 135] used 190 µm and 25 µm while Lee et 
al. [16] utilized 300 µm and 5 µm for the entering and exiting channel heights, respectively.  
Cells start to sediment as soon as they enter the chip, with the sedimentation rate 
depending on cell diameter as well as fluid properties such as kinetic viscosity and density. To 
promote successful cell trapping, it is required that cells roll on the channel floor when 
arriving at the microwells [135] making the average flow velocity a significant parameter. 
Kim et al. [135] performed a numerical simulation for modeling this phenomenon by 
considering the cells to be 10 µm in diameter and taking cell-wall and cell-cell interactions 
into account. According to the flow rates and channel dimensions reported by Kim et al. [88, 
135], the suitable average flow velocity can be calculated to be approximately 300 µm/sec 
[88] and 500 µm/sec [135] in the channels. With these velocities, no shear stress-induced cell 
damage was declared; meanwhile, cell trapping was carried out successfully [88, 135]. 
Lee et al. designed a hydrostatically-driven flow µSFC based on the hydraulic-electric 
analogy [16]. After introducing the cell suspension at the inlet, the device was tilted by 90 
degrees to promote cell sedimentation into the trap chambers for spheroid formation. The 
authors adjusted the height of the exiting channel of the trap chamber such that its flow 
resistance was approximately one thousand times larger than that of the main channel. 
Therefore, the flows conducted through the trap chambers were identical. After spheroid 
formation, the spheroids could be perfused under continuous culture medium flow or retrieved 
by changing the flow direction in the device (Figure 16D) [16].  
2.1.3. Other microfluidic chips for spheroid formation 
In this section, we describe other microfluidic designs for spheroid formation and culture 
including pyramid microwells, porous membranes, and microrotational flow. Their pros and 
cons are discussed briefly to help designers create their microfluidic chip more efficiently.  
Torisawa et al. designed a µSFC containing pyramid-shaped microwells with holes at 
their vertex to facilitate on-chip scanning electrochemical microscopy (SECM) (Figure 7A) 
[151]. The spheroid formation took place in the microwells first. Afterwards, the microwells 
were inverted to perform SECM analysis while spheroids were hanging from the microwells, 
a configuration resembling the HD method. 
 
 
Porous membranes have been used in µSFCs to dictate cell patterning necessary for on-
chip mono- [155] and co-cultured [156] spheroid formation. Figure 7B shows a two-layered 
hydrostatically-driven µSFC in which a porous membrane was placed between the two layers 
to filter cells behind its pores. Each layer of the µSFC had microchannels, some of which 
were connected to microchannels within the other layer using the porous membrane [156, 
157]. Hsiao et al. placed the spheroid formation chambers lateral to the main channel of the 
top layer, facilitating single spheroid formation and enhancing size uniformity [156]. Kuo et 
al. used the same principle for spheroid formation with pores being 10 µm in diameter while 
in other similar devices, the pore size was 5 µm [155]. The cell trapping efficiency of the 
device was at most 97% which signified its low cell waste. Recently, we have shown that 3D 
spheroid culture is possible on electrospun PDMS nanofibers [158]. By integrating this 
membrane in a microfluidic platform, several biological studies on 3D cell culture samples 
would be feasible. 
Microrotational flow was proven to induce spheroid formation in microfluidic chips by 














acceptable size controllability and short times - as rapidly as 120 seconds. Spheroid sizes 
ranging from 130 to 430 µm with a standard deviation of less than 17.2% can be achieved by 
changing cell concentration in the cell suspension entering the device. In the first design, 
spheroids could be cultured only for one day because the spheroids started to exit from the 
chambers afterwards [123]. In the second design, the device was integrated to facilitate HTSF 
[122]. Even though spheroids remained in the chambers for more than one day, unwanted cell 
aggregates still existed and had to be removed by a filter. This indicates that a fraction of cells 
introduced to the device did not take part in the spheroid formation process and were therefore 
wasted. Another deficiency of this method is that it requires a large volume flow rate of 
culture medium (1.2 ml/min) in comparison with microwell-based techniques [122, 152]. 
Sound waves were recently used by Chen et al. [10] in a novel µSFC that integrated 3D 
acoustic tweezers (Figure 7D). The device could simultaneously form 150 spheroids within 
less than 30 minutes using various cell lines including HepG2, HEK 293, SH-FY5Y and 
HeLa cells. The rapidity of spheroid formation limited the necessary exposure time of cells 
within the acoustic field, reducing cell death caused by sound waves.  
A microfluidic design exists that provides steady-state perfusion to spheroids [159] or 
cell aggregates [153, 160] while avoiding shear stress on the cells. In this design, micropillars 
were used to minimize the direct exposure of spheroids to the flow of culture medium, 
confining the transport phenomena to diffusion - as occurs in in-vivo microenvironments. To 
culture spheroids in this chip, pre-formed spheroids were inserted into the center channel and 
then the flow of culture medium was established through the side channels [159] (Figure 7E). 
Tung et al. [54] designed a novel HD platform (Figure 7F) to optimize the procedure 
traditionally used for HD spheroid formation [161]. The platform was compatible with liquid 
handling robots as well as conventional 384 & 96-well plate readers utilized in high-
throughput drug screening. Although these advancements were significant for the spheroid 
formation and culture experiments, inherent design characteristics limit the capacity to 
properly mimic in-vivo microenvironments. Liquid evaporation within the wells and droplets 
leads to increased osmolality that can negatively impact cell viability [54, 162]. Specific 
amounts of culture medium should be interchanged manually with the delicate droplets every 
day to compensate for the evaporated liquid.  
Recently, the inability to establish dynamic microenvironments in HD platforms has been 
solved by novel HD-based microfluidic designs [154, 163]. In a valuable work by Yazdi et al. 
[154], both pulsatile and steady-state flows were created through the device by pneumatic 
actuation, mimicking the in-vivo microenvironment and thereby enhancing the culturing of 
human cardiac iPS-derived spheroids (Figure 7G). These platforms enabled closed-loop 
circulation of medium, but still required the addition of fresh culture medium to compensate 
for evaporation [163]. 
2.2. Microfluidic spheroid culture-only chips (µSCCs) 
µSCCs are designed to provide suitable microenvironments for cell spheroid culturing 
and drug tests. Importantly, cell spheroids must first be formed using other platforms and then 
transferred to a µSCC. Perhaps reflecting this limitation, µSCCs are not as prevalent as the 
µSFCs in the literature. Indeed, spheroid retrieval and transfer, combined with spheroid 
formation using other devices (conventional techniques), may make this approach relatively 
laborious and expensive in terms of time and experimental cost. Nonetheless, in this section 
several µSCCs are described for a better understanding of these devices. 
Munaz et al. fabricated a µSCC which had a wide main channel followed by parallel 
narrow microchannels of 80 µm width, 60 µm apart from each other [87]. Pre-formed 
spheroids were injected into the chip through the main channel and hydrodynamically 
directed to the narrow microchannels. The spheroids were trapped behind the narrow 
microchannels at a flow rate of 30 µl/min. The authors reported that flow rates above 60 














colleagues also designed a µSCC using the hydraulic-electric analogy so that flow resistance 
in bypass channels was more than trapping channels, facilitating efficient spheroid trapping 
(Figure 8B) [8]. They reported that shear stress was negligible and did not affect the cells 




Kim et al. designed a µSCC that had eight microchambers for spheroid culturing [89]. 
Following loading, the spheroid entered a microchamber which resembled a vertical hollow 
cylinder. In the device, culture medium flow was generated by tilting the platform (Figure 8C). 
Astolfi and co-workers designed a microfluidic chip to culture micro dissected tissues whose 
sizes were identical to cell spheroids (380 µm in diameter) [139]. Their design included a 
channel that contained several flat-bottomed microwells to trap the dissected tissues (Figure 
8D). Using simulation, they determined that high flow velocities caused these tissues to 
escape from the microwells, while the simultaneous shear stress was not high enough to have 
adverse effects on cells.  
Some multi-organ-on-a-chip devices use liver spheroids as the suitable 3D culture for 
liver lobules [164, 165]. In fact, the spheroids are introduced to the specific chambers and 
microchannels on the chip to be co-cultured with other organs such as pancreatic microtissues 
[165], skin tissue, intestine, and kidney cells [164]. The circulatory flow within the device 
exposes the spheroids to the metabolites and the materials secreted by other organ cells to 
mimic the in-vivo relations and functions of the organs. 
3. Digital microfluidics in spheroid formation and culture 
Digital microfluidics is a state-of-the-art technique used to handle picoliter to microliter 
liquid droplets [166, 167] using different mechanisms such as the Marangoni effect [168], 
magnetic fields [169, 170], optical actuation [171] or electrostatic forces [172-174]. Recently, 
much attention has been given to the application of this format of microfluidics in various 
biomedical applications including assisted reproductive technology and in vitro fertilization 
[175]. It has been shown that the electrostatic fields used in digital microfluidic chips have 
negligible effects on cell viability, morphology [174, 176] and gene expression [172], making 
such platforms suitable for both 2D [174, 176, 177] and 3D [172, 173, 178] cell culture. This 
microfluidic approach has facilitated more realistic and accurate experiments than those 
carried out in multiwell plates for toxicity screening [172, 179], invasion assays [173] or cell 
polarization assays using spheroids [172]. In this method, liquid droplets are introduced into 
the chip to form sub-droplets (passive dispensing) and directed to HD holes (Figure 9A) [180] 
or hydrophilic sites (Figure 9B) [181, 182] to be anchored. The sub-droplets take the shape of 
HD holes or hydrophilic patterns and are therefore outstanding at creating the desired droplet 
structures [178]. It is also possible to deliver reagents, drugs and any other liquid solutions to 
the anchored droplets on the chip without any pumps or valves [178]. 
 
 
Using on-chip crosslinking, Eydelnant and co-workers created cell-containing microgel 
structures in a digital microfluidic chip [178]. They reported spheroid formation from Madin 
Darby canine kidney (MDCK) cells in Geltrex and type I collagen microgel structures. They 
successfully probed on-chip spheroid polarization and 3D kidney epithelialization. Another 
digital microfluidic chip was designed for hepatotoxicity and albumin analysis as well as 
enzymatic activity assays on liver HepG2 spheroids [172]. The device performed droplet 
merging, mixing and splitting as well as dilution of solutions by digitally actuating the 
droplets on the chip. Another platform used HDs on the chip to form fibroblast and colon 
cancer cell spheroids for invasion assays [172]. Although digital microfluidics appears to have 














evaporation, lack of continuous perfusion, complex control and fabrication [167] as well as 
biofouling [179]. Some of these limitations have recently been addressed, but others remain to 
be eliminated. 
4.  Statistical comparison and a brief summary of µSFCs and µSCCs  
Figure 10 compares the standard deviation (SD) of spheroid diameter and formation time 
duration resulted from various spheroid formation methods. The formation time is considered 
as the time elapsed before cells make an aggregate in the culture as reported by the authors. 
As seen in the figure, the emulsion and the liquid overlay technique have the smallest and the 
largest SDs. Microrotational flow device had the shortest formation time due to the specific 
flow field in this condition which brings the cells close to each other, sufficient for developing 
cell-cell bonds in only 120 seconds. The well-based methods, although having larger SDs, 
facilitate spheroid formation in a shorter time than the emulsion technique. Occupying the 
smallest SD and formation time amongst the conventional methods, the HD method appears 
to be the best one which is comparable with the microfluidic methods.  
 
 
There are more than 40 cell types used on various µSFCs and µSCCs so far, which are 
mostly the cell lines presented in Figure 11. Primary cells such as lung adenocarcinoma [39] 
and rat hepatocyte cells [68] have been rarely used in single- [68] and co-culture [39, 89] with 
other cell lines on µSFCs [39] and µSCCs [89]. The majority of µSFCs and µSCCs conducted 
chemosensitivity tests using anticancer drugs such as duxorubicin [134], paclitaxel [134], 
cisplatin [7], 5-fluorouracil [10] while only two works recently presented photodynamic 
therapy on lung (A549 and MRC-5) [183] and breast cancer cell lines (T47D, MCF-7 and 
SUM159) [13] on µSFCs.  
 
 
For summarizing the information presented in Section 2, a table is added briefly show the 
















5. Design considerations and affecting parameters of µSFCs and µSCCs 
Several parameters influence the microfluidic environment of a spheroid cell culture as 
illustrated in Figure 12. The impacts and traits of these parameters should, therefore, be 
investigated properly prior to design and fabrication. In this section, some of these key 




5.1. Microstructure design for spheroid formation and culture 
Hemispherical or U-shaped microstructures are appropriate geometries for guiding 
uniformly sized spheroid formation. When a number of cells are trapped within a 
hemispherical geometry, the resultant microforce exerted on the cells by the round wall 
improves spheroid compaction since the force focuses on the center (Figure 13A). Therefore, 
the bottoms of microwells and cell trapping microstructures in multiwell culture plates and 
µSFCs are designed as concave shapes [6, 39, 40]. This hemispherical shape also helps with 
the single spheroid formation in each microwell [39, 184]. Ruppen et al. suggested that after 
two days of culture, most of the concave-bottomed microwells contained one spheroid, while 
flat-bottom microwells mostly contained two or three [39]. 
One method to create concave-bottomed microwells in PDMS microfluidic chips is to 
fabricate flat-bottomed microwells first and then pour PDMS prepolymer on the microwells. 
Next, the prepolymer should be raked out by a flat plate (Figure 13B). The remaining 
prepolymer in the flat-bottomed microwells forms a concave geometry due to surface tension 
between the PDMS liquid prepolymer and the PDMS solid surface [40]. Xu and colleagues 
proposed a novel method for concave-bottom fabrication by controlling the temperature and 
pressure of trapped air bubbles [125]. They fabricated the desired number of microcavities on 
a poly (methyl methacrylate) plate. PDMS was poured onto the plate but it did not fill the 
microcavities due to its high viscosity. To achieve this viscosity, the PDMS was cooled to      
-20˚C. By increasing the temperature and reducing the pressure in an incubator, the air 
bubbles expanded and pushed up the adjacent PDMS layer to form the desired concave 
microwells (Figure 13C). Ruppen et al. used a fabrication procedure, involving four different 
castings, to make concave-bottomed microwells [39]. First, flat-bottomed microwells were 
fabricated using stereolithography (3D printing). Following double casting with silanization, 
the flat-bottomed microwells were transferred to PDMS.  Then, uncured PDMS droplets were 
deposited onto micropillars to form the desired hemispherical shapes. Last, the final mold was 
obtained by casting an epoxy onto the PDMS hemispherical substrate (Figure 13D). 
Pneumatics can also be used to generate temporary microwells or U-shaped 
microstructures in µSFCs. Anada and co-workers generated membrane deformations by 
establishing pressure differences across a thin, flexible PDMS slab, thereby producing 
concave-bottomed microwells [185]. After spheroids were formed, the pressure difference 
was eliminated. As a result, the microwells completely disappeared and the spheroids were 
delivered at the outlet.  
 
Permanent [118, 121] and temporary pneumatically-actuated [119, 120, 128] U-shaped 
microstructures were fabricated on PDMS µSFCs inside microchannels. Unlike temporary U-
shaped microstructures, the permanent ones were inflexible and consequently did not allow 
proper spheroid retrieval. Poly (ethylene glycol) diacrylate, which is a non-adherent hydrogel, 
was also used instead of PDMS to fabricate the U-shaped microstructures [118].  
The design of spheroid culture microenvironments in µSCCs usually have the intended 
characteristics to facilitate the specific test on the spheroids. In a recent design, the authors 
investigated the effect of shear stress on chemoresistance and stemness of ovarian cancer 














microchannels suitable for exposing the spheroids under controlled shear stresses of 0.02 and 
0.002 dyne/cm2. In a design by our group, spheroids were introduced to a µSCC for fusion of 
olfactory ensheathing cell spheroids [87]. The device contained parallel narrow channels after 
a wide chamber behind which spheroids trapped. The channels were close enough to enable 
the spheroids make bonds between themselves while being under culture medium perfusion. 
For drug toxicity, various designs exists which differ in the mechanism of spheroid trapping 
and culture [8, 89, 139]. They share a mutual feature which is having spheroid culture sites far 
from direct exposure of spheroids from the flow of culture medium. The primary goal of the 
design in these devices is to avoid the spheroids from high shear stresses to remove any 
chances of cell death caused by it. 
5.2. Culture medium delivery 
The µSFCs and µSCCs are designed for various purposes such as drug cytotoxicity 
assesment [39], study the effect of shear stress on the spheroids [186], multi-organ culturing 
[164] and various other applications not developed yet. With this in mind, various flow 
conditions in the chip are needed that the designers should be familiar with them.  A number 
of pumping methods are currently used within microfluidic chips for delviery of the culture 
medium  [187]. These include: hydrostatic pressure differences [16], peristaltic micropumps 
[123, 188], osmotic pressure differences [40, 68, 189], passive pumping [190] and syringe 
pumps [88, 98]. 
In hydrostatic pumping, the pressure difference comes from the difference between the 
liquid levels of the inlet and outlet ports (Figure 14A). To maintain a fixed flow rate in 
microchannels, one needs to add liquid to the inlet or remove it from the outlet reservoirs 
which otherwise the flow rate becomes transient [7, 89, 155]. In HD-based µSFCs where 
culture medium experiences high rates of evaporation and osmolality changes, the transient 
flow cannot perfectly control the medium solute concentrations. Recently, Ong et al. designed 
a hydrostatically-driven µSFC in which the flow rate maintained constant to address the 
problem of transient flow [191]. 
Peristaltic pumping is used within cell culturing microfluidic chips [187]. Mousavi et al. 
designed a thermoplastic polyurethane diaphragm adopted from a plug-and-play microvalve 
to facilitate peristaltic fluid pumping for cell culture applications (Figure 14B) [188]. 
Peristaltic pumping is widely used for imposing cyclic shear stresses on endothelial cells 
[187] and also to better mimic the in-vivo blood flow for cardiac microtissue spheroids [154]. 
Osmotic pumping  has been used in µSFCs for continueous medium supply to hepatocyte 
spheroids [40, 68].  In osmotic pumping, adjusting the concentration of the driving agent 
(such as polyethylene glycol) enables flow controllability [40, 68]. Fabrication is possible by 
simply gluing a cellulose membrane as a window to a PDMS chamber containing water [192] 
(Figure 14C). Although it enables nanoliter flows, the flow rate decreases as the time goes by 
due to the gradual reduction of the driving agent and requires constant refilling of the medium 
chamber and driving agent. 
In µSFCs and µSCCs this type of flow condition provides time-variable supply of 
nutrients while the cell spheroids consume the nutrients and produce metabolic wastes 
constantly. 
Passive pumping is also a practical method for microfluidic cell culture. As reported by 
Berthier and Beebe [190], the flow has two phases in this system. In the first phase, the flow 
is almost constant which is the most noticeable feature of this method. However, in the second 
phase, the flow velocity decreases in the microchannels until it ceases. It is possible to refill 
the inlet droplet manually to maintain the flow; however, it would be laborious to maintain 
such perfusion for long-term culture (Figure 14D).  
Among the above-mentioned techniques, despite being costly and occupying a large 
space, syringe pumps are often the most practical and suitable pumping method. They operate 














chip which is needed in most experiments in which tumor spheroids are under 
chemosensitivity studies [39, 149, 193].  
 
5.3. Shear stress 
One of the most crucial considerations in microwell and microchannel design within 
µSFCs and µSCCs is the shear stress to which cultured spheroids are exposed, since high 
shear stresses may cause spheroid disaggregation [40]. More subtly, Chang et al. reports that 
high shear stress on cancer cells modifies cell cycle, differentiation, and gene expression 
profile [195]. The maximum allowable shear stress on various mammalian cells, reported by 
different authors, falls into a large range from 0.001 [196] to 10 dyne/cm2 [197]. This 
illustrates that acceptable shear stress differs for distinct cell lines.  
In a recent work by Zuchowska et al., they investigated the effect of shear stress on 
spheroids formed on a µSFC. They reported that high shear stresses (maximum of 0.9 
dyne/cm2) had adverse effects on forming cell aggregations and spheroid formation of A549 
cell line while it did not affect MRC-5 cell spheroids [198]. According to their observations, 
A549 spheroids were formed more compactly in deep microwells (500 µm height) due to 
lower shear stresses in comparison with shallower ones (350 µm height). It is likely that the 
difference between the morphology of the cells is responsible for this outcome. In another 
work in which ovarian cancer cell spheroids were put under various shear stresses in a µSCC 
the authors claimed that under in-vivo relevant shear stresses similar to the condition in 
peritonium (<0.1 dyne/cm2), the cancer cell spheroids showed higher chemoresistance and 
also exhibited a higher tendency towards tumorigenesis. In addition, it was shown that the 
cancer stem cells in the spheroids induced stem cell markers only under shear stress and not in 
static culture [186]. It can be concluded that the shear stress is a critical parameter in 
designing µSFCs and µSCCs as it affects cellular function and phenotype [199].  
Creating geometries that generate low velocities and stagnation regions near spheroids 
leads to low shear stresses on cells [121]. In designing a µSCC, CFD analysis was performed 
to examine three different designs to optimize the geometry with respect to shear stress [89]. 
U-shaped microstructures and microwells also have the potential to be further refined with the 
aid of CFD analysis to limit shear stresses on cells [65]. For instance, the depth of microwells 
should be designed such that it is sufficient to protect spheroids from high shear stresses, 
particularly as they settle. Similarly, microwell diameters should be configured to ensure that 
spheroids do not exceed a specific size range [65]. Another way to protect multicellular 
spheroids from high shear stresses is to encapsulate them in hydrogel droplets [37]. In this 
way, the cells are not in direct contact with the main flow. 
5.4. Cell loss 
One drawback of most µSFCs is that cells may be lost during chip loading. This problem 
is more pronounced when the number of available cells is low, as is the case with primary 
cells and clinical samples. When cells are introduced at the inlet of the device, many of them 
do not trap within the chip. For instance, in most microwell-based µSFCs, cells that do not 
sediment within microwells are rinsed out with the flow of culture medium [6, 17, 40, 95, 
125]. Therefore, many cells exit the device without taking part in the spheroid formation 
process. However, recent advances in µSFC design have resolved this issue [39, 88, 98, 155, 
156, 200]. Gradually decreasing the depth of microwells can dramatically reduce the number 
of cell lost [39, 88, 135]. Using porous membranes for cell trapping is also useful [155, 156, 
200]. Emulsion-based µSFCs do not usually allow cell loss since cells are encapsulated inside 
either the aqueous phase [149] or the hydrogel droplets [36].  
5.5. Spheroid diameter and cell density 
Various parameters influence spheroid diameter in a single µSFC. These include: cell 














dimensions (Figure 15C and D) [7, 13, 125]; duration of cell seeding [39, 88, 98, 151]; and 
flow rate of the cell suspension [88, 98, 120].  
In order to achieve desired diameters, one should take cell size into account. Patra et al. 
used different cell densities for HepG2 and COS-7 cell lines (107 and 105 cells/ml 
respectively), producing spheroid diameters of 200 µm and 80 µm, respectively [96]. This 
indicates that COS-7 cells are much larger than HepG2 cells. In another study, human glioma 
(U251) cells, human hepatocellular liver carcinoma (HepG2) cells, and human breast 
adenocarcinoma (MCF-7) cells were used to from spheroids using the same cell density of 
5×106 cells/ml. However, the resulting spheroid sizes were considerably different, as shown 
in Figure 15A.  
In a µSFC, cell density is a critical parameter responsible for spheroid size (Figure 15B). 
In microwell-based µSFCs, low cell densities lead to the formation of several small spheroids 
per well [17]. In contrast, excessive cell densities produce large and fragile aggregates that do 
not resemble spheroids. These loose aggregates lack spherical shape [185] and may clog 
microchannels [17]. Chen et al. investigated the effects of cell suspension density in a µSFC 
[134]. The authors reported that cell densities below 1×106 cells/ml led to compact spheroids 
after 24 hours, while a density of 2×106 cells/ml (for HCT116 cells) caused loose cell 
aggregates. Anada et al. reported similar results for cell densities above 4×106 cells/ml using 
HepG2 cells [185]. They also tried spheroid formation with a density of 8×106 cells/ml with 
the MG63 cell line and obtained compact spherical spheroids. These results show that the 
higher limit for cell density in a µSFC not only depends on the device design specifications 
but also on cell type. 
 
 
Changing microwell dimensions is another way to generate different spheroid sizes from 
the same cell line (Figure 15C & D) [7, 125]. Patra et al. generated spheroids with diameters 
of 130 and 212 µm simply by adjusting the microwell dimensions [7]. The cross-sectional 
shapes of their microwells were squares with 200×200 µm and 300×300 µm dimensions 
(Figure 15C). Another design by Kim et al. allowed precise control on spheroid diameter by 
tuning three parameters simultaneously: flow rate, cell density, and duration of cell seeding 
[88, 135]. At equal cell seeding times, it is possible to increase cell density while lowering the 
flow rate and thereby obtain equivalent spheroid diameters. Sakai et al. reported that high 
culture medium flow rate increased the spheroid diameter by bringing the fresh medium and 
nutrients, and removing the waste products from the spheroid formation sites [201].  
The addition of some factors can enhance the spheroid formation and its sphericity [202]. 
Increasing the fetal bovine serum (FBS) [163], reconstituted basement membrane (rBM) [48] 
or collagen [198] concentration in the culture media can enhance cell aggregation. Frey and 
co-workers investigated the effect of FBS concentration on spheroid formation of human 
colorectal carcinoma cells (HCT-116) in a µSFC. The authors reported that 0% concentration 
of FBS led to no spheroid formation while higher concentrations promoted larger diameter 
spheroids [163]. The spheroids produced from lung carcinoma cells (A-549 cell line) cultured 
on a µSFC were observed to improve sphericity and compaction only after the addition of 
collagen due to their low secretion of ECM proteins [198].  
5.6. Methods of spheroid analysis 
Evaluating and monitoring the spheroids before, during and after culturing and drug tests 
are crucial for interpreting the functionality of µSFCs and µSCCs. The monitoring methods 
are conducted off-chip or on-chip. Here, we briefly overview the off-chip techniques and then 
discuss the microfluidic designs to facilitate off-chip spheroid analysis. Finally, the recent 
advances in on-chip spheroid monitoring tools are elaborated. 














  Methods used conventionally for spheroid analysis can be categorized into two types. 
The first group needs spheroid retrieval which includes flow cytometry [7], scanning electron 
microscopy [36, 203, 204] and transmission electron microscopy [28]. The first group 
methods are typically conducted after the experiments and are solely endpoint assessment 
tools. The second group uses the supernatants collected from the outlet microchannels of the 
chip to evaluate the viability and metabolic activity of the cells after drug treatment [8, 39, 
164] by conducting measurement of metabolites concentration, luminescence, and absorbance 
with the plate readers [39]. The supernatants contain caspase [8, 39], albumin [89], urea [40], 
glucose and lactate content [164] which can be used to determine the cellular apoptosis and 
functional conditions in the culture microenvironment on the chip. Parallelization is an option 
which can be considered to boost the total throughput for supernatants analysis which should 
be considered in the chip design. Although these methods are simple and easy to use, they are 
not efficient for online monitoring because the supernatant is usually extracted during the 
experiment and stored for later measurements.    
The capacity to retrieve spheroids from µSFCs represents a significant capability, 
allowing researchers to obtain additional information about cell viability, apoptosis and 
necrosis using flow cytometry [7], or to distinguish differentiation states in the case of stem 
cells [189]. Accordingly, proper mechanisms for the retrieval of the spheroids are essential. 
Spheroid retrieval is facilitated by the careful design of microchannels, microwells, and 
microstructures on µSFCs. After spheroids are formed, they can be retrieved by reversing [16, 
149] and/or increasing the flow rate [7, 96, 139], or by pneumatic actuation [119-121, 128, 
185]. 
Mcmillan et al. [149] and Lee et al. [16] retrieved spheroids by reversing the flow 
direction in the device (Figure 16A and Figure 16B). The reversed flow exerts a higher 
pressure on spheroids in the opposite direction, forcing them to move back to the spheroid 
outlet. Several works including µSFCs [7, 96] and µSCCs [65, 139] retrieved spheroids by 
increasing the flow rate of the culture medium. They first simulated the flow field in square 
microwells to obtain the flow rate at which spheroids exit microwells due to hydrodynamic 
lift forces. Then, they applied this numerically obtained flow rate to their µSFC for spheroid 
retrieval. Xu et al. used two strategies for spheroid retrieval [125]. They either implemented 
high flow velocities (6 mm/sec) or inverted the device. As a result of the second technique, 
the spheroids could be retrieved with much lower fluid velocities (500 µm/sec). This method 
can reasonably reduce potential cell damage caused by high shear stress.  
 
 
Recently, a number of pneumatics approaches has been utilized in µSFCs that allow 
spheroid retrieval. After spheroids are formed, and drug tests are completed, the 
pneumatically activated U-shaped barriers move downward, allowing spheroids to move 
towards the chip outlet [119, 120, 128] (Figure 16C). In a two-layered µSFC fabricated by 
Anada et al., the pressure inside the bottom channel was reduced to deform the membrane 
[185]. Thus, concave-bottomed microwells were formed as a result of the pressure difference 
across a thin, flexible PDMS membrane (Figure 16D). After spheroid formation, the pressure 
difference was set to zero such that concave-bottomed microwells reverted to a flat surface. 
Spheroids were then simply retrieved via pipetting. 
In µSFCs or µSCCs lacking spheroid retrieval capacity, it is necessary to perform precise 
drug monitoring and screening on the chip. By turning the chip upside-down, Kang et al. 
developed a microfluidic platform that facilitated the formation and spontaneous 
differentiation of stem cell spheroids within microwells [189]. A flat area existed above each 
microwell on which spheroids fell. That area was pretreated with laminin and poly-L-lysine to 














capacity, the need for spheroid retrieval was obviated by enabling on-chip differentiation and 
experimental monitoring. 
5.6.2. On-chip spheroid analysis methods  
Cellular viability and 3D morphology of the spheroids can be evaluated on-chip by using 
optical microscopy (Figure 16A(b) & A(c))  [120, 205], fluorescent microscopy (Figure 
16A(b) & A(c)) [8, 105, 120], the non-destructive spectroscopic imaging [206], confocal 
microscopy [52, 105, 173] and scanning electrochemical microscopy (SECM) (Figure 7A) 
[151]. In on-chip live/dead fluorescent staining of the spheroids, the projected areas of green 
and red regions are quantified as live or dead portions of the spheroid following 
chemosensitivity tests. Non-fluorescent assessment of live/dead viability and sphericity of the 
spheroids [203] can be done using image processing software (e.g., ImageJ and MATLAB) by 
on-chip measuring the spheroid diameter every day as it changes as a result of cell 
proliferation or cell death [134].  
Real-time monitoring of glucose consumption and lactate secretion of cell spheroids 
using electrode-based biosensors is implemented on an HD-based µSFC similar to the one 
shown in Figure 7G [207]. The electrodes were fabricated by metal deposition on a glass layer 
in the chip and were functionalized with a hydrogel coating containing lactate or glucose 
oxidase on them. The hanging droplets were in contact with hydrogels from their ceiling 
which enabled in situ monitoring of lactate (Figure 17A). The mentioned microfluidic HD 
concept was integrated into another work by Schmid et al. for electrical impedance 
spectroscopy [208]. Two pairs of platinum electrode inlays were deposited on a glass and 
placed in the HD culture similar to the previous design. The electrodes were placed lateral to 
the HD center in a way that each pair of them had various distances to it. Those placed farther 
were used for HD height measurements, and those placed closer to the center measured 
spheroid diameter size by quantifying the output current values for specific magnitudes of the 
applied voltage and signal. The measurements were based on the impedance changes of the 
HDs and spheroids due to their size and the resulting changes in the electrical field. Alexander 
et al. recently fabricated an on-chip platform for the measurement of extracellular 
acidification, oxygen uptake rate of cell spheroids, temperature and electrical impedance in a 
µSCC [209]. They pipetted the pre-formed spheroids into a 3D-printed cylindrical microwell 
in the chip which was confined with two membranes having 120 µm pores from the bottom 
and above (Figure 17A). The thin layered deposited microelectrodes were embedded below 
the microwell to measure the chamber pH and the oxygen consumption of HepG2 spheroids 
(Figure 17B). The device was coupled with a digital interface for user monitoring and 
automatic flow control of the chip. The non-invasive and label-free characteristics of these 
biosensors make them suitable tools for chemosensitivity monitoring and microenvironment 
control of cell spheroids in µSFCs and µSCCs. 
 
6. Conclusions and future directions  
In the present review, the application of microfluidics technology to the spheroid 
formation and culturing was discussed to illuminate its potential and benefits, as well as the 
challenges that remain relative to conventional cell culture methods. Various methods and 
techniques utilized in microfluidic spheroid formation and culture were described. These 
include microwells and U-shaped microstructures, the hydraulic-electric analogy, digital 
microfluidics and spheroid culture-only chips, as well as other creative designs related to 
µSFCs and µSCCs. In addition, the design considerations and affecting parameters relating to 
µSFCs and µSCCs were also discussed to provide a better understanding of the various 
parameters affecting on-chip spheroid formation and culture.  
A common shortcoming among most of the existing µSFCs and µSCCs in the literature is 
their inability to facilitate high-throughput screening (HTS) in high-throughput spheroid 














needs a large number of microwells or microstructures to form numerous spheroids, while 
HTS requires the capacity to deliver different drug doses to each of those spheroids. Such 
drug delivery must occur within the microchannels on the chip, each having a specified 
concentration of the desired drug. Designing such a platform, despite being complex, would 
address the deficiencies of conventional HTS platforms such as multiwell or 384 hanging 
droplet (HD) plates. Methods and protocols for spheroid HTS have been devised using 
multiwell plates but unfortunately, retain the disadvantages of static cultures. 
Despite advancements in the field of microfabrication, microfluidic platforms are 
intended to be used only once. In addition, since microfabrication processes are still 
considered expensive, using microfluidic drug screening platforms has not yet become 
common. Recent progress in 3D printing technology can be considered as a “killer 
application“ in microfluidic cell culture platforms [210]. This technology enables rapid and 
inexpensive fabrication of various 3D microfluidic devices with complex integrated 
components. In addition, these microfluidic cell cultre devices can become much more 
efficient when used for HTS. This would facilitate easy handling and manipulation especially 
when the procedures can be carried out using automated and robot-actuated devices in 
biological laboratories. Using robotics for the handling of the µSFCs and µSCCs not only 
minimizes the human-made errors but also makes the procedure easier for the future end-users.  
In most µSFCs and µSCCs, the capacity to retrieve the cultured multicellular spheroids is 
limited. Typically, either there is no possibility for spheroid retrieval or it requires high flow 
rates that can adversely affect cell viability. Thus, efficient spheroid retrieval is an essential 
factor that merits increased design focus for implementation in µSFCs and µSCCs. Integration 
of µSFCs and µSCCs with imaging tools is another way to better analyze cultured spheroids. 
Embedding microlenses within the microfluidic chip for online monitoring can be helpful in 
platforms where spheroid retrieval is not possible. On-chip spheroid monitoring and sensing 
with biosensors and spectrometry tools also are interesting subjects. The electrode-based 
biosensors recently conducted on µSFCs and µSCCs have shown encouraging results 
regarding their capability in measuring and controlling the culture microenvironment species 
concentrations such as lactate, glucose, oxygen and also giving the pH, electrical impedance 
and temperature in situ. It is predicted that by using these biosensors and coupling them with 
the user-friendly interfaces, these platforms will have entered the realm of commercialization.   
One of the missing components in on-chip spheroid culture is the administration of 
mechanical stress on the spheroids to better mimic the in-vivo microenvironments. By 
integrating the µSFCs and µSCCs with micromechanical actuators, it will be possible to 
conduct chemosensitivity tests and expose the spheroid cells to the in-vivo-like extracellular 
forces. Another future direction which can be seen for on-chip spheroids culturing is the 
application of bioengineered scaffolds in the µSFCs and µSCCs. The scaffolds can provide 
suitable surroundings for the spheroids to recapitulate the neighboring tissues. 
 Introducing the non-spherical spheroids to the µSCCs is feasible because in-vivo tumors 
are not spheres per se. Thus, various in-vivo relevant geometries of cellular aggregates can be 
bioprinted off-chip and then introduced to a µSCC. By these cellular structures, some other 
aspects of the spheroids features will be explicitly revealed when these non-spherical shapes 
are also vascularized and consisted of various relevant cell types. Inevitably, these advances 
depend on the creation of more developed microfabrication and microfluidics techniques 
which are not out of reach in the near future.  
While such advances represent essential directions for development, µSFCs and µSCCs 
have clearly shown their potential in 3D culture and drug screening. These devices have been 
keenly studied for over a decade, yet have not reached maturity and still need to become more 
robust and easy to handle. Their ability to mimic in-vivo microenvironments must still be 
improved to more closely recreate complex phenomena, such as angiogenesis and 














accelerating, indicating that the impact of these platforms will continue to expand and 
advance across the biomedical research field.  
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Figure 1. Tumor spheroid characteristics. (A) The three cell layers, distinguished by the 
rate of proliferation; (B) oxygen concentration gradient in tumor spheroid; (C) the pH gradient 
shows the existence of an acidic environment in the core as a result of anaerobic activities; 
(D) shows cells and the surrounding ECM in a co-cultured tumor spheroid. 
 
Figure 2. Emulsion-based techniques for spheroid formation. (A) (a) Schematic 
illustration of a single-emulsion (Gel/O) droplet generator for the formation of uniform water 














flow-focusing microfluidic device; (b and c) an overview and composition of the actual 
microfluidic device. Reproduced with permission from [100]. (B) (a) Schematic overview of a 
microfluidic device for multicellular spheroid production. The system is composed of an 
external fluidic injection system, coextrusion microdevice, and off-chip gelation bath; (b) 
Confocal image of an alginate capsule stained with high-molecular-weight fluorescent 
dextran; (c) Plot of the capsule aspect ratio as a function of the flow rate; and (d) Phase-
contrast pictures of individual capsules encapsulating cells. Reproduced with permission from 
[101]. (C) (a) Schematic overview of a three-dimensional microfluidic system for generation 
of core-shell microcapsules for efficient formation of cell spheroids; (b) Representative phase-
contrast micrographs of individual capsules encapsulating cells. Reproduced with permission 
from [98]. 
 
Figure 3. (A) Single-emulsion (Gel/O) droplet generation chip for spheroid generation 
having sinusoidal anchoring array for (a) single cell type encapsulation ; (b and c) T-junction 
for droplet formation and droplets entering the array before gelation; (d) Gelled cell-laden 
alginate spheroids; (e) Live cells stained with Calcein-AM. Reproduced with permission from 
[36]). (B) Single-emulsion (CS/O) spheroid formation device containing sinusoidal anchoring 
arrays. (a) Device overview showing the inlets and the anchoring array having 2000 droplet 
sites; (b) Droplet formation and cell encapsulation. (c and d) Brightfield images of cells 
encapsulated within droplets and trapped within the anchoring array (Reproduced with 
permission from [103]). (C) Single-emulsion (Gel/O) device using microwells to anchor cell-
dispensed hydrogel droplets. (a) A schematic showing the oil and the hydrogel inlets and 2200 
anchoring sites within the blue area; (b) Droplet production stage and the V-shaped trails for 
distributing the droplets over the anchoring sites. Reproduced with permission from [104]. 
(D) Another single-emulsion (Gel/O) chip producing droplets having magnetic particles on 
which magnetic force is exerted to deviate their pathway from the oil flow (pink) to the 
culture medium flow (blue). (a) Schematic depicting the overall view of the microfluidic chip; 
(b) The droplet generation section has four inlets: one dedicated to mineral oil and the others 
for CaCl2, culture medium and cell dispensed alginate hydrogel solved in culture medium; (c) 
A microscopic image of the separation channel. The magnet attracts the gelled droplets 














oil. The broken line indicates the path line of a droplet. Reproduced with permission from 
[105]. 
 
Figure 4. U-shaped microstructures in µSFCs: (A) A pneumatically actuated µSFC 
containing U-shaped microstructure arrays. It contains eight chambers for high-throughput 
cell trapping and spheroid formation. (a) The two images depict the microchip fabricated out 
of PDMS; (b) Top and sectional view of one of the U-shaped microstructures comprised of 
three layers; (c) Schematic diagrams of high-throughput cell loading and localization within 
the chip. Reproduced with permission from [128]. (B) Permanent U-shaped microstructures. 
(a) The configuration of the alginate encapsulated beads instantly after droplet formation, in a 
Petri dish; (b) This figure depicts the droplets four days after being trapped in the microsieve 
structures for spheroid formation. The gaps between the microsieves enable proper diffusional 
nutrient and gas exchange. Reproduced with permission from [18]. (C) A µSFC containing 
permanent U-shaped microstructures. (a) A representation of an in-vivo tumor provided by 
drug molecules from blood vessels; (b) The microchip constructed by PDMS/glass slide; (c 
and d) the flow of culture medium towards the microstructure pushes the cells inside. Drug, 
nutrient and waste molecules are perfused to the trapped cells with the flow through the 2 μm 















Figure 5. Spheroid formation process in a microwell-based µSFC: (A) Introduction of a 
cell suspension to the chip inlet. The cell suspension fills all the microchannels and 
microwells rapidly due to the capillary effect; (B) Cells start depositing on the bottom of the 
microchannels and microwells; (C) Pure culture medium flows through the chip to rinse the 
excess cells without disturbing the cells lying on the microwell bottom; (D) Cell secretions 
and signaling lead to establishment of cell-cell interactions on the non-adherent microwell 















Figure 6. Parts A to D depict microwell-based µSFCs in which each microchannel feeds 
several spheroids. In the parts E and F each main microchannel branches into several 
microchannels which individually feed each microwell. (A) A graphic demonstration of a 
microchip for MTS formation and drug screening. (a) Each microchannel feeds a 3×11 
configuration of microwells. The formation of a cell spheroid on a microwell displayed at the 
bottom left, and a micrograph of the microwell-array of the chip is shown at the bottom right; 
(b) Top and side visions of the microchip.  Reproduced with permission from [134]. (B) A 
microwell-based µSFC for evaluating the efficacy of Photo Dynamic Therapy on tumor 
spheroids. (a) Graphical representation of cells trapping in a microwell; (b) Schematic of cell 
aggregation after 1 day; (c and d) The structure of the 3D microfluidic chip; (e) The fabricated 
chip that has 1024 microwells within a main area of 2 cm by 2 cm. Reproduced with 
permission from [13]. (C) Photographs of a two-layered µSFC, and the magnified view of the 
square spheroid culture microwells in the inset. Reproduced with permission from [96]. (D) A 
µSFC integrated with a CGG to facilitate high-throughput drug tests. Each drug is delivered 
to three microchambers in series, each containing 14 microwells. The distance between 
microchambers was designed such that the µSFC is compatible with conventional plate 
readers. Reproduced with permission from [6]. (E) A microwell-based µSFC having (a) Cells 
are trapped within each microwell due to the difference between the inlet and outlet 
microchannel heights; (b) Top-view of two microchannels filling with color food dyes 
(yellow and red). The length of the microchannels delivering cell suspension to each 
microwell is equal to facilitate uniform-sized spheroid formation; (c) The microchip’s mold 
made of epoxy. Reproduced with permission from [39]. (F) A microwell-based µSFC 
designed using the hydraulic-electric analogy to facilitate spheroid culture of the same cell 
numbers in all the microwells. (a) It contains one inlet for cell seeding, eight inlets for drug 














flow rates are adjusted by the hydrodynamic resistance of the microchannels; (c) The uniform 
flow rates in each microchannel estimated by hydrodynamic simulation. Reproduced with 
permission from [88]. 
 
Figure 7. Other types of µSFCs: (A) A µSFC compatible with SECM due to silicon 
pyramid-like holes. (a) The cross-section of the microchip is depicted and its layers are 
shown; (b) The figure shows the microchip after spheroids have been formed in the structures 
resembling HDs; (c) The SECM measurement was done on the microchip while it was 
inverted on a glass slide to avoid spilling of the measurement liquid. Reproduced with 
permission from [151]. (B) Cell trapping behind a porous membrane for spheroid formation, 
facilitated by the flow of the cell suspension through the membrane. The spheroid formation 
is carried out by: (a) cell seeding, (b) cell trapping behind the porous membrane and (c) cell 
aggregation. (C) Microrotational flow in a microchamber having two inlets and outlets 
embedded in a three-layered µSFC. The inlet and outlet channels are tangential to the cylinder 
in the middle layer and the upper layer, respectively, to promote rotational flow. Reproduced 
with permission from [152]. (D) Spheroid formation by the aid of 3D acoustic tweezers. (a) 
The overall view of the microchip is shown; (b) Diagram of Gor'kov potential field inside the 
cavity. The balance among the acoustic radiation force, microstreaming drag force, gravity 














spheroids are formed in the microchannel where the potential field exists; the generated 
spheroids are then placed in a Petri dish.  Reproduced with permission from [10]. (E) Cells 
are entered through the central inlet channel and trapped in the central chamber to form 
spheroids. The chamber is separated from the surrounding flow, which comes through the side 
inlets, by micropillars which are located close to each other. Reproduced with permission 
from [153]. (F) HD spheroid formation in an HD plate: (a) introduction of the cell suspension 
within the holes; (b) formation of the droplet by the capillary forces, (c) creation of an HD, (d) 
cell aggregation, (e) spheroid formation after one day. Redrawn after [54]. (G) an HD based 
µSFC. (a) The figure depicts (1) the pneumatic chamber is pressurized to create a flow from 
the central HD to the right HD (2). (3) The left valve, which prevented backflow, is now open 
while the pneumatic chamber is unpressurized. Figure (4) shows the spheroids in the HDs; (b) 
an image of the HD based µSFC which is colored by food dyes. Reproduced with permission 
from [154]; 
 
Figure 8. The figure depicts various µSCCs. (A) A µSCC for culturing olfactory 
ensheathing cell spheroids. (a) This device consists of two inlets: one large well (6 mm) for 
culture medium and a smaller one (2 mm) for spheroid injection. Parallel microchannels, 80 
µm in width for spheroid trapping, are embedded within the device through which the culture 
medium passes and feeds the spheroids; (b) the device also integrates lateral chambers for 
trapping unwanted air bubbles entering the device. Reproduced with permission from [87]. 
(B) The microchannels are designed using the hydraulic-electric analogy in which the 
trapping channel has less flow resistance than the bypass channel before spheroid trapping. 
Reproduced with permission from [8]. (C) A hydrostatic pressure-driven µSCC containing 
two units each having one perfusion and four loading microchannels. (a) Medium reservoirs 
are situated at both ends of each perfusion microchannel; (b) the spheroid culture chamber is 
placed at the intersection of the loading and the perfusion microchannel; (c) to load spheroids, 
the device is slanted with respect to axis No. 1 in figure (a); (d) After spheroid loading into 
the chambers, flow is created by periodic tilting of the device around axis No. 2 to obtain 
hydrostatic pressure difference between the inlet and outlet. Reproduced with permission 
from [89]. (D) A µSCC consisting of five parallel sinuous microchannels each of which 
contains five microwells for sedimentation trapping of the loaded microtissues or spheroids. 
(a) Loading microtissues or spheroids into the chip by a micropipette; (b) The microchip with 














view of the microtissue in the microchannel which is reaching the microwell trap; (d) the 
microchip made of PDMS with five inlet reservoirs. Reproduced with permission from [139]. 
 
Figure 9. Digital microfluidic chips for spheroid formation. (A) An HD-based digital 
µSFC. As shown in the figure, the platform design is complex and needs several materials 
such as Aluminum, Parylene-C, silicon oil, etc. as well as high resolution in fabrication (400 
and 110 nm layers). A cell suspension is first introduced to the device inlet. Then, droplets are 
guided to the sites where the holes exist by the aid of capillary forces in order to form HDs 
and spheroids consequently. The humidified environment is provided by a buffer to prevent 
droplet evaporation for the long-term experiment. Reproduced with permission from [173]. 
(B) The process of droplet manipulation and anchoring in a digital microfluidic chip: (a) 
introducing the first droplet to the chip and guiding it to the hydrophilic site; (b) anchoring of 
the first droplet and introducing the second droplet to the first droplet; (c) the droplet moves 
across the hydrophilic site to facilitate the formation of a droplet similar to the hydrophilic 
















Figure 10. The figure shows spheroid diameter standard deviation (the black columns) 
and formation time (the orange line) collected from a myriad of previous studies. The data 
belong to microfluidic and conventional methods for spheroid formation, displaying 
microfluidics’ superior advantages in forming spheroids with a shorter time and also size 
uniformity. The SD extends from 4% for the emulsion technique to 16.6% for the 
microrotational flow µSFC. The formation time also differs significantly from the stirred tank 















Figure 11: The figure depicts the various cell lines used for spheroid formation and co-
culture assays on µSFCs and µSCCs. The bars show the percentage of the µSFCs or µSCCs in 
which these cell lines have used for spheroid formation and culture. For instance, the HepG2 
cell has been used in almost 16.5% of the works found in the literature. To show the co-
culture assays, the cell lines used have been attached together with the black lines. For 
example, in one work, the MCF-7 and the MDA-MB-231 cell lines are co-cultured. 
 
 
Figure 12. The design considerations which need to be considered for spheroid formation 














Figure 13. (A) Illustration of the microforces acting on cells in a (a) flat-bottomed and 
(b) concave-bottomed microwell. Figures B to D depict fabrication methods to generate 
concave-bottomed microwells for spheroid formation: (B) creating concave-bottomed 
microwells using PDMS prepolymer by: (a) pouring the PDMS prepolymer on the 
microwells; (b) raking out the liquid meniscus and (c) thermal curing for PDMS solidification. 
Redrawn after [40]. (C) Using air expansion to induce concave shape on PDMS slab: (a) air is 
trapped in the microwell due to the high viscosity of cold PDMS; (b) during baking of PDMS, 
the air expands and pushes the PDMS upward. After baking, the PDMS slab is peeled off and 
used. Redrawn after [125]. (D) This method utilized silanization treatment to enable multi-
casting of PDMS. All PDMS curing took place at 60˚C for 2h. (a) Mold is filled with PDMS 
and cured. (b) After silanization a second PDMS is produced and cured. (c) A little drop of 
PDMS is added on every well to round it and cured. (d) After silanization a 3rd PDMS cast is 
produced and cured. (e) After silanization the PDMS mold is filled with the epoxy (Weildling 
C) and cured at 40˚C for 24h. (f) Final epoxy mold with round bottom wells. Reproduced with 















Figure 14. Various methods for flow pumping in microfluidic chips. (A) Hydrostatic 
pressure drives flow through a µSFC. Reproduced with permission from [7]. (B) Peristaltic 
pump designed by Mousavi et al. [188]. (a) Schematic view of the micropump consisting of 
three layers which are two PDMS layers in the top and bottom of the device in addition to a 
diaphragm layer (red). By inducing low pressures in the air entry, flow is promoted from the 
suction port to the central chamber. Conversely, when applying high pressure in the air entry, 
the liquid in the chamber flows towards the discharge port; (b) cross-sectional view, showing 
the air and the liquid ports; (c) overall view; (d) the diagram of the pumping flow rate vs. 
pressure difference of the micropump. Reproduced with permission from [188]. (C) 
Schematic view of an osmotic pump designed by Park et al. comprised of water in a glass 
tube, a PDMS chamber containing water and a cellulose membrane [192]. The chamber is 
placed in a dish containing poly (ethylene glycol) solution in order to encourage liquid flow 
from the cellulose membrane to the dish. Reproduced with permission from [192]. (D) 
Passive pumping is facilitated by: (a) putting droplets at the inlet and the outlet channels 
having different volumes; (b) promotion of flow through the device from the smaller droplet 
to the larger one as a result of Laplace pressure difference caused by liquid surface tension. 















Figure 15. Different spheroid diameters formed by specific strategies. (A) Spheroid 
formation of cells having varied volumes in pneumatically-actuated microstructures. (a) 
Human glioma (U251) cell spheroids cultured for 10 days; (b) Fluorescence photography 
from Ki67 (red) and nuclear staining (blue) of U251 tumor spheroids after 10 days of 
culturing. The top right image indicates cell proliferation using fluorescence imaging of Ki67 
in a spheroid cultured for 10 days in the µSFC; (c) human breast adenocarcinoma (MCF-7) 
cell spheroids after 10 days of culturing; (d) human hepatocellular liver carcinoma (HepG2) 
cell spheroids after 5 days of culturing. These cell lines have the same cell densities in the 
suspension which consequently results in distinct spheroid diameters for each cell line. 
Reproduced with permission from [128]. (B) Using various cell densities in the introduced 
cell suspension leads to differently-sized spheroids. Here, MG63 and HepG2 cell spheroids 
are shown after 5 days of culturing. Reproduced with permission from [185]. (C) Two sets of 
dimensions for square-sectioned microwells are shown. (a) Top view of the microwells 
having sides of 200 and 300 µm; (b) side cross-section view of the two sets of microwells. 
Reproduced with permission from [7]. (D) Various microwell diameters of C1, C2, C3 and C4 
were used for spheroid formation. Images are taken on days 0, 1 and 3 after culturing from 















Figure 16. Summary of various methods used for spheroid retrieval in µSFCs. (A) (a1 to 
a4) The time-lapse image sequence of spheroid retrieval by reversing the flow direction; (b 
and c) brightfield and fluorescent images of the retrieved spheroids proved the success of the 
retrieval process. Reproduced with permission from [149]. (B) Spheroid retrieval by 
pneumatic actuation of a PDMS membrane. (a) Cell loading to the microchip; (b) blocking the 
flow by pressurizing the PDMS membrane to trap cells; (c) spheroid formation; (d) releasing 
the pressure to free the spheroids for retrieval. Reproduced with permission from [120]. (C) 
Forming microwells using PDMS membrane by pneumatic actuation. The acrylic resin plate 
contains many holes and is placed above the air chamber in the bottom layer of the microchip. 
The air chamber is connected to a vacuum pump with a silicon tube to induce pressure 
difference across the membrane.  Reproduced with permission from [185]. (D) The procedure 
for spheroid generation and retrieval in a µSFC. (a)  Loading cells by a pipette; (b) orienting 














perfusion flow; (e) spheroid retrieval by reversing the flow direction in the chip. Reproduced 
with permission from [16]. 
 
Figure 17: (A) An HD-based µSFC integrated with a biosensor for lactate and glucose 
measurements; (a) schematic view of the device having 8 HD sites of 3.5 mm diameter and 
the orientation of the biosensor on the chip; (b) the electrode-based biosensor is displayed. 
The sensor consists of four working platinum electrodes, one platinum counter electrode and 
an Ag/AgCl reference electrode; (c) the cross-section views A and B clarify the flow in the 
microchannels and the yellow glass plug-ins on which the sensors are deposited. Reproduced 
with permission from [207]; (B) A cross-sectional view of the µSCC (a) and the sensor chip 
(b) designed by Alexander et al. [209]; (a) It consists of a fluidic channel in the top, three 1 
mm diameter microwells containing the spheroids and a sensor microchip in the bottom of the 
porous membranes; (b) the sensor chip measures the pH of the microenvironment (pH1 and 
pH2 sensors), oxygen uptake rate by the cells (pO2 amperometric sensor), temperature (T) and 
electrical impedance (Imp1 and Imp2) by the electrodes shown in the figure. Reproduced with 
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 Hydrogel type: The solid-like nature 
of the hydrogels might hinder 
spheroid formation 
 Droplet stabilization: adding 
surfactants improves droplet 
stability and spheroid formation 
 Flow rate: controls droplet 
generation frequency, droplet 
diameter and shell thickness 
 Droplet anchorage: prevents droplet 
coalescence. The anchorage sites 









actuated or permanent 
structures 
 They can be used to trap both cells 
and cell containing droplets for 
spheroid formation. 
 The structure size controls the 
spheroid diameter. 
 The stagnation pressure in front of 
the structures facilitates spheroid 
formation. 
 The configuration of their location 
with respect to each other on-chip is 








trapping or flow rate 
trapping 
 Spheroid escape from the 
microwells can be predicted by CFD 
simulations and prevented. 
 The flow rate and cell paths through 
spheroid culture microchannels 
should be adjusted and equalized 
using hydraulic-electric analogy. 
 To facilitate HTS, the microchip 
should be designed such that it can 








Other methods used 
on-chip hanging 
droplets, permeable 
membranes, 3D acoustic 
tweezers, micropillars 
and microrotational flow 
for spheroid formation 
 Porous membranes are used in two-
layered chips for patterning the cells 
next to each other. 
 The microrotational flow design 
requires a large volume flow rate of 
culture medium. 
 The exposure time of cells within 
the on-chip 3D acoustic field is 















 The micropillars are used to 
minimize the direct exposure of 
spheroids to the flow-induced shear 
stress and confine the transport 
phenomena to diffusion. 
 On-chip hanging droplets have 
closed-loop steady and pulsatile 
culture medium flows for spheroid 
formation and culture. They still 
need adding culture medium to 













microwells with square 
sections 
 The design of µSCCs have the 
intended characteristics to facilitate 
the specific test on the spheroids. 
 The hydraulic-electric analogy is 
used to direct the spheroids towards 
the culturing sites on-chip. 
 Spheroids are used as the suitable 






This method uses 
HDs or hydrophilic sites 
on the chip for spheroid 
formation 
 This method does not need any 
valves or pumps. 
 Droplet merging, mixing and 
splitting as well as dilution of 
solutions are possible on digital 
microfluidic chips. 
 Biofouling, liquid evaporation and 
lack of continuous perfusion are its 
deficiencies. 
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